COVID-19
5,276
148
281
2,848
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
622 trials with published results (12%)
Research Maturity
2848 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
407 terminated out of 5276 trials
87.5%
+1.0% vs benchmark
13%
665 trials in Phase 3/4
22%
622 of 2848 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2848 completed trials
Clinical Trials (5276)
POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests.
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test
Genetics of COVID-19 Susceptibility and Manifestations
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.
The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates
Comprehensive Imaging Exam of Convalesced COVID-19 Patients
Study of VYD2311 for the Prevention of COVID-19
Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19
Pulmonary Function in Patients Recovering From COVID19 Infection : a Pilot Study
Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients
A Longitudinal Study of COVID-19 Sequelae and Immunity
COVID-19 Experiences in the SELF Cohort
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19